Lọc theo
Vắc-xin tái tổ hợp, hấp phụ phòng 9 týp vi-rút HPV ở người
In the treatment of patients with axial spondyloarthritis (axSpA), the dual IL-17A/F inhibitor bimekizumab appears to lower the risk of uveitis, according to a study.
Children with parapneumonic effusion (PPE) or pleural empyema (PE) are often overly treated with antibiotics, particularly the frequent use of antibiotic combination therapy, reports a Germany study.
Nicotinamide riboside supplements show a signal of benefit for helping patients with lower extremity peripheral arterial disease (PAD) walk more
Children with influenza A virus infection are susceptible to acute benign myositis (ABM), with most patients showing clinical characteristics consistent with postfebrile myalgia, reports a study.
The use of Janus kinase (JAK) inhibitors in the treatment of major autoimmune diseases appears to reduce the risk of age-related macular degeneration (AMD) for people above 40 years of age, according to a study.
Treatment with oral roflumilast results in reduced body weight and appetite after 24 weeks in patients with psoriasis, a study has shown.
A retrospective review of medical records show that paediatric patients with alopecia areata (AA) in Singapore respond well to currently available treatments.
Treatment with ixekizumab resulted in almost 90 percent of children with active juvenile psoriatic arthritis (JPsA) or enthesitis-related arthritis (ERA) achieving an ACR30* response by week 16, according to the ongoing COSPIRIT-JIA trial presented at EULAR 2024.
A new tool for identifying potentially inappropriate prescribing (PIP) in people with type 2 diabetes (T2D) has been validated in the outpatient setting, according to an Ethiopian study.
